Delivery Order SPE2DR25D1109-SPE2DR26FFJ0P
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $3,832.33 to supply Trulicity 0.75 mg/0.5 ml pens. This competitive, firm fixed-price delivery order is scheduled for completion by October 22, 2025, and represents a continuation of the company's pharmaceutical supply services supporting federal military and veteran healthcare systems. The award carries no set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,453.70. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 26, 2025, and will be performed at the awardee's facility in Conshohocken, PA. The award represents a child order under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 20, 2025, for Trulicity 0.75 mg/0.5 ml pens valued at $4,850.62. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and performance will occur at the vendor's Conshohocken facility. The award represents a child contract executed under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 5, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $4,088.04. The award is structured as a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,051.05 firm fixed-price delivery order on June 17, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 ml pens. This delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 23, 2025, for the supply of Trulicity 3 mg/0.5 ml pens. The contract carries a ceiling value of $5,723.04 and features firm fixed-price pricing with an ultimate completion date of June 24, 2025. This is an unset-aside, competitively awarded delivery order representing a single-line item pharmaceutical procurement. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,922.70 by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract utilized firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be completed at the vendor's Conshohocken facility, with an ultimate completion date of November 26, 2025....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,907.40 by the Defense Logistics Agency (DLA) on November 24, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. This firm fixed price, non-set-aside contract is designated as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFJ0PDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,453.41 on December 15, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of December 16, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and is funded by the Defense Logistics Agency (DLA), a defense agency component of the Department of Defense. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. Trulicity is a diabetes management medication that falls within the broad portfolio of pharmaceutical products and medical supplies that AmerisourceBergen delivers to support military healthcare programs worldwide. The delivery order will be fulfilled from the company's facility in Conshohocken, Pennsylvania, where the company maintains operations to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's successful award of this delivery order reflects the company's demonstrated capability to compete for and fulfill federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 12/14/25 |